Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
- PMID: 33717758
- PMCID: PMC7952276
- DOI: 10.7759/cureus.13251
Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
Abstract
The WATCHMAN (Boston Scientific, Marlborough, USA) is a device used to occlude the left atrial appendage (LAA) in patients of non-valvular atrial fibrillation (NVAF) with a high CHA2DS2-VASc score who are poor candidates for oral anticoagulation. LAA perforation is a well-known complication of the WATCHMAN device placement. Here we present two cases of NVAF where oral anticoagulation was not advisable due to recurrent bleeding episodes. They underwent the WATCHMAN procedure for stroke prevention. During the placement of the WATCHMAN device into the left atrial appendage (LAA) in both cases, pericardial staining was noted that worsened over the next few minutes. It was decided to deploy the 27 mm WATCHMAN device into the LAA. In one case, satisfactory hemostasis was achieved with the device deployment eliminating the need for cardiothoracic surgery. However, the second case led to pericardial tamponade and was managed by the placement of a pericardial window. To our knowledge, this is the first case series describing the use of a WATCHMAN device upon detection of LAA perforation.
Keywords: device deployment; hemostasis; left atrial appendage perforation; pericardial staining; pericardial tamponade; watchman.
Copyright © 2021, Prabhakar Bhat et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


References
-
- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Blackshear JL, Odell JA. Ann Thorac Surg. 1996;61:755–759. - PubMed
-
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Holmes DR, Reddy VY, Turi ZG, et al. Lancet. 2009;374:534–542. - PubMed
-
- The PROTECT AF (WATCHMAN left atrial appendage system for embolic PROTECTion in patients with Atrial Fibrillation) trial. Fountain RB, Holmes DR, Chandrasekaran K, Packer D, Asirvatham S, Van Tassel R, Turi Z. Am Heart J. 2006;151:956–961. - PubMed
-
- Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. Reddy VY, Gibson DN, Kar S, et al. J Am Coll Cardiol. 2017;69:253–261. - PubMed
-
- Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Veinot JP, Harrity PJ, Gentile F, et al. Circulation. 1997;96:3112–3115. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources